- Home
- FBIOP vs EVR Comparison
FBIOP vs EVR Comparison
Compare FBIOP & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- EVR
- Stock Information
- Founded
- FBIOP N/A
- EVR 1995
- Country
- FBIOP United States
- EVR United States
- Employees
- FBIOP 186
- EVR N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- EVR Investment Managers
- Sector
- FBIOP Health Care
- EVR Finance
- Exchange
- FBIOP Nasdaq
- EVR Nasdaq
- Market Cap
- FBIOP N/A
- EVR N/A
- IPO Year
- FBIOP N/A
- EVR 2006
- Fundamental
- Price
- FBIOP $5.75
- EVR $210.12
- Analyst Decision
- FBIOP
- EVR Buy
- Analyst Count
- FBIOP 0
- EVR 6
- Target Price
- FBIOP N/A
- EVR $293.40
- AVG Volume (30 Days)
- FBIOP N/A
- EVR 779.8K
- Earning Date
- FBIOP N/A
- EVR 04-23-2025
- Dividend Yield
- FBIOP N/A
- EVR 1.52%
- EPS Growth
- FBIOP N/A
- EVR 42.54
- EPS
- FBIOP N/A
- EVR 9.08
- Revenue
- FBIOP N/A
- EVR $2,980,251,000.00
- Revenue This Year
- FBIOP N/A
- EVR $18.88
- Revenue Next Year
- FBIOP N/A
- EVR $19.48
- P/E Ratio
- FBIOP N/A
- EVR $23.14
- Revenue Growth
- FBIOP N/A
- EVR 22.85
- 52 Week Low
- FBIOP N/A
- EVR $175.24
- 52 Week High
- FBIOP N/A
- EVR $324.06
- Technical
- Relative Strength Index (RSI)
- FBIOP 35.47
- EVR 44.95
- Support Level
- FBIOP $5.50
- EVR $191.64
- Resistance Level
- FBIOP $6.74
- EVR $221.31
- Average True Range (ATR)
- FBIOP 0.27
- EVR 8.01
- MACD
- FBIOP -0.08
- EVR 2.40
- Stochastic Oscillator
- FBIOP 20.00
- EVR 62.29
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.